Although the function of platelet LRRC32 thus remained elusive, Rachidi and colleagues, however, recently reported that conditionalgarp/lrrc32deletion in platelets improves adoptive T-cell therapy as tumor treatment in mice.46Therefore, the role of platelet LRRC32 may perhaps be more related to inflammation and immune regulation, rather than to thrombosis and hemostasis, as was suggested in the zebrafish model. Here, LRRC32 is linked to neoplasm.